Dietary supplementation with N-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial

Lancet

Volumn 354, Issue 9177, 1999, Pages 447-455

  Marchioli, Roberto ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SECONDARY PREVENTION; STROKE;

EID: 0345109256     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)07072-5     Document Type: Article

References (60)

1. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiological and clinical trial data. Ann Intern Med 1995; 123: 860-72.
2. Simopoulos AP. Omega-3 fatty acids in health and disease and growth and development. Am J Clin Nutr 1991; 54: 438-63.
3. Simopoulos AP. ω-3 fatty acids in the prevention-management of cardiovascular disease. Can J Physiol Pharmacol 1997; 75: 234-39.
4. Marchioli R, Di Pasquale A, per i Ricercatori GISSI-Prevenzione. Il quadro di riferimento biochimico, farmacologico, epidemiologico del GISSI-Prevenzione. G Ital Cardiol 1993; 23: 933-64.
5. Bang HO, Dyerberg J, Hjørne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976; 200: 69-73.
6. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; ii: 757-61.
7. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-56.
8. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-49.
9. Kushi LH, Folsom AR, Prineas RJ, et al: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334: 1156-62.
10. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological, and clinical trial data. Pharmacol Res (in press).
11. Steinberg D, and workshop participants. Antioxidants in the prevention of human atherosclerosis. Circulation 1992; 85: 2337-44.
12. Steinberg D. Antioxidants and atherosclerosis: a current assessment. Circulation 1991; 84: 1420-25.
13. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
14. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
15. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-86.
16. Meydani M, Natiello F, Goldin B, et al. Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr 1991; 121: 484-91.
17. Gruppo Italiano Studio sulla Sopravvivenza nell'Infarto miocardico (GISSI). Il protocollo dello studio GISSI-Prevenzione: Studio di intervento preventivo sulle componenti aterosclerotica e trombotica del rischio post-infarto. G Ital Cardiol 1993; 23: 1053-61.
18. Santoro E, Franzosi MG, Nicolis E. A computerized network system for the management of a large-scale multicentre clinical trial: the GISSI-3 trial. Control Clin Trials 1993; 14: 430.
19. Graziani MS, Ceriotti F, Carobene A, et al on behalf of SIBioC Prevenzione Group. Accuracy of cholesterol measurements in Italian clinical laboratories: joint project GISSI-Prevention Italian Society of Biochemistry. Eur J Clin Chem Clin Biochem 1997; 35: 311-15.
20. Stampfer MJ, Buring JE, Willett W, Rosner B, Eberlein K, Hennekens CH. The 2X2 factorial design: its applications to a randomized trial of aspirin and carotene in U.S. Physicians. Stat Med 1985; 4: 111-16.
21. Byar DP, Piantadosi S. Factorial designs for randomized clinical trials. Cancer Treat Rep 1985; 69: 1055-62.
22. Marubini E, Valsecchi MG, eds. Analysing survival data from clinical trials and observational studies. Chichester, UK: John Wiley, 1995.
23. De Vita C, Franzosi MG, Geraci E, et al. GISSI-2 mortality plus extensive left ventricular damage as "end-points". Lancet 1990; 335: 289.
24. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake and the risk of coronary disease among men. N Engl J Med 1995; 332: 977-82.
25. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279: 23-28.
26. Kromhout D, Bosschieter EB, de Lezenne CC. The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-09.
27. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336: 1046-53.
28. Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc Soc Exp Biol Med 1992; 200: 177-82.
29. Rodriguez BL, Sharp DS, Abbott RD, et al. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers: The Honolulu Heart Program. Circulation 1996; 94: 952-56
30. De Lorgeril M, Salen P, Martin J-L, Moniaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
31. Singh RB, Rastogi SS, Verma R, et al. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ 1992; 304: 1015-19.
32. McLennan PL. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 1993; 57: 207-12.
33. McLennan PL, Bridle TM, Abeywardena MY, Charnok JS. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J 1992; 123: 1555-61.
34. Kang JX, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids: recent studies. Circulation 1996; 94: 1774-80.
35. Billman GE, Kang JX, Leaf A. Prevention of ischemia-induced ventricular arrhythmias by dietary pure n-3 polyunsaturated fatty acids in dogs. Circulation 1999; 99: 2452-57.
36. Sellmayer A, Witzgall H, Lorenz RL, Weber PC. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol 1995; 76: 974-77.
37. Christensen JH, Gustenhoff P, Eilersen E, et al. n-3 fatty acids and ventricular extra systoles in patients with ventricular tachyarrhythmias. Nutr Res 1995; 15: 1-8.
38. Christensen JH, Korup E, Aaroe J, et al. Fish consumption, ω-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997; 79: 1670-73.
39. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain ω-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363-67.
40. Kang JX, Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1994; 91: 9886-90.
41. Kang JX, Leaf A. Prevention and termination of the β-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem Biophys Res Commun 1995; 208: 629-36.
42. Kang JX, Xiao Y-F, Leaf A. Free, long-chain, polyunsaturated fatty acids reduce membrane electrical exicitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1995; 92: 3997-4001.
43. Xiao Y-F, Kang JX, Morgan JP, Leaf A. Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1995; 92: 1100-04.
44. Xiao Y-F, Wright SN, Wang JK, Morgan JP, Leaf A. n-3 fatty acids suppress voltage-gated Na+ currents in HEK2931 cells transfected with the α-subunit of the human cardiac Na+ channel. Proc Natl Acad Sci USA 1998; 95: 2680-85.
45. Xiao Y-F, Gomez AM, Morgan JP, Lederer WJ, Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1997; 94: 4182-87.
46. Marchioli R, Bomba E, Tognoni G. Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. Lancet 1996; 347: 467-68.
47. Mitchinson MJ, Stephens NG, Parsons A, Blight E, Schoefield PM, Brown MJ. Mortality in the CHAOS trial. Lancet 1999; 353: 381.
48. Ness A, Davey Smith G. Mortality in the CHAOS trial. Lancet 1999; 353: 1017-18.
49. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alphatocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction. Lancet 1997; 349: 1715-20
50. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
51. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease, part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
52. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-16.
53. Marchioli R, Tognoni G. Beneficial effects of statins. Lancet 1996; 348: 1542.
54. Vaugham CJ, Murphy MB, Buckley BM. Statins do more than just lowering cholesterol. Lancet 1996; 348: 1079-82.
55. Princen HMG, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vase Biol 1995; 15: 325-33.
56. Suzukawa M, Ishikawa T, Yoshida H, Nakamura K. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 1995; 14: 46-52.
57. Weber P, Bendich A, Machlin LJ. Vitamin E and human health: rationale for determining recommended intake levels. Nutrition 1997; 13: 450-60.
58. Porkkala-Sarataho EK, Nyyssonen MK, Kaikkonen JE, et al. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg α-tocopherol on the oxidation resistance of atherogenic lipoproteins. Am J Clin Nutr 1998; 68: 1034-41
59. De Waart FJ, Moser U, Kok FJ. Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL. Atherosclerosis 1997; 133: 255-63.
60. Omenn GS. What accounts for the association of vegetables and fruit with lower incidence of cancers and coronary heart disease? Ann Epidemiol 1995; 5: 333-35.